Cara Therapeutics Inc (CARA)

15.86
0.53 3.20
NASDAQ : Health Care
Prev Close 16.39
Open 16.19
Day Low/High 15.53 / 16.21
52 Wk Low/High 4.26 / 23.61
Volume 900.05K
Avg Volume 2.38M
Exchange NASDAQ
Shares Outstanding 32.42M
Market Cap 538.51M
EPS -2.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cara Therapeutics Announces Positive Data From Quantitative Phase 1 Trial Measuring Respiratory Safety Of I.V. CR845

Cara Therapeutics Announces Positive Data From Quantitative Phase 1 Trial Measuring Respiratory Safety Of I.V. CR845

- I.V. CR845 statistically equivalent to placebo across all measures of respiratory safety -

Jim Cramer -- Incyte Stock Is Red-Hot, Worth More Than $200 in a Takeout

Jim Cramer -- Incyte Stock Is Red-Hot, Worth More Than $200 in a Takeout

Incyte has been doing great, locking in deals with Bristol-Myers and Merck. It's worth a lot more in a takeover situation, Cramer said.

Fed Crashes the Party: Cramer's 'Mad Money' Recap (Wednesday 4/5/17)

Fed Crashes the Party: Cramer's 'Mad Money' Recap (Wednesday 4/5/17)

Jim Cramer stresses discipline here because, he says, a frothy market can quickly turn on investors.

5 Stocks Insiders Are Loading Up On

5 Stocks Insiders Are Loading Up On

Insiders at Tesla, Ford and three other companies have been scooping up shares of their own stock lately.

Health Care Vote Impacts Trump's Deal Maker Image

Health Care Vote Impacts Trump's Deal Maker Image

At stake is whether the Republicans can work out their differences.

First Week Of November 17th Options Trading For Cara Therapeutics (CARA)

First Week Of November 17th Options Trading For Cara Therapeutics (CARA)

Investors in Cara Therapeutics Inc saw new options become available this week, for the November 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Cara Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results

Cara Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results

- Conference call today at 4:30 p.m. ET -

4 Small-Cap Biotech Stars

4 Small-Cap Biotech Stars

I'm still enthusiastic about the sector, but it is critical to also be prudent.

4 Small-Cap Biotech Stars

4 Small-Cap Biotech Stars

I'm still enthusiastic about the sector, but it is critical to also be prudent.

Market Action Is Boring but Necessary

Market Action Is Boring but Necessary

After yesterday's surprise pullback, this is the sort of consolidation we need.

Market Taking a Break, but Probably Not for Long

Market Taking a Break, but Probably Not for Long

Today is more about stock picking.

Why Cara Therapeutics Is Up, Trevena Down

Why Cara Therapeutics Is Up, Trevena Down

Readers want to know what to do with the two biotech names, which are headed in opposite directions.

First Week of April 21st Options Trading For Cara Therapeutics

First Week of April 21st Options Trading For Cara Therapeutics

Investors in Cara Therapeutics Inc saw new options begin trading this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CARA options chain for the new April 21st contracts and identified one put and one call contract of particular interest.

Here Are 5 Stocks With Unusual Volume

Here Are 5 Stocks With Unusual Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst

Here's What 'Superinvestors' Are Doing During the Latest Surge in the Stock Market

Here's What 'Superinvestors' Are Doing During the Latest Surge in the Stock Market

Here's a technical look at how to trade a number of stocks rising with unusual volume flow.

Check Point Software, Sanchez Energy, Aecom Technology: 'Mad Money' Lightning Round

Check Point Software, Sanchez Energy, Aecom Technology: 'Mad Money' Lightning Round

Jim Cramer is bullish on Check Point Software, CyberArk Software, Sanchez Energy and Aecom Technology.

Winners and Losers in the Wake of Apple's Earnings: Cramer's 'Mad Money' Recap (Wednesday 2/1/17)

Winners and Losers in the Wake of Apple's Earnings: Cramer's 'Mad Money' Recap (Wednesday 2/1/17)

Jim Cramer details the impact of Apple's earnings on the whole economic ecosystem, and says Apple is the new mall.

Cannabis Stocks Do Not Trade on Earnings, Instead on Pipeline of Drugs

Cannabis Stocks Do Not Trade on Earnings, Instead on Pipeline of Drugs

Cannabis stocks are not affected by the volatility in prices during earnings season and instead trade on positive data such as potential FDA approval on their pipeline of drugs.

First Week of March 17th Options Trading For Cara Therapeutics (CARA)

First Week of March 17th Options Trading For Cara Therapeutics (CARA)

Investors in Cara Therapeutics Inc saw new options begin trading this week, for the March 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CARA options chain for the new March 17th contracts and identified one put and one call contract of particular interest.

Tech, Energy and Financial Stocks Are Set to Reap Highest Returns for Investors in 2017

Tech, Energy and Financial Stocks Are Set to Reap Highest Returns for Investors in 2017

Investors seeking less volatility can reap better returns in 2017 by allocating funds in sectors such as technology, biotech, energy and financials, which should generate above average performance.

Short Interest Makes 17.5% Move For CARA

Short Interest Makes 17.5% Move For CARA

The most recent short interest data has been released for the 12/15/2016 settlement date, which shows a 746,049 share increase in total short interest for Cara Therapeutics Inc , to 5,008,642, an increase of 17.50% since 11/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.